MeSH Pharmacological ClassificationCompounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Applications
UsesErbstatin, a EGFR kinase inhibitor, possesses antineoplastic effect[1][2].